A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS
Stopped commercial reason
Conditions
- Acute Myeloid Leukemia
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Higher Risk Myelodysplastic Syndrome
- Chronic Myelomonocytic Leukemia
Interventions
- DRUG: Bisantrene Dihydrochloride (high dose)
- DRUG: Bisantrene Dihydrochloride (low dose)
- DRUG: Cytarabine Hydrochloride
- DRUG: Decitabine and cedazuridine
Sponsor
Racura Oncology Ltd
Collaborators